Valproic Acid Increases Formation of Reactive Oxygen Species and Induces Apoptosis in Postimplantation Embryos: A Role for Oxidative Stress in Valproic Acid-Induced Neural Tube Defects
Authors:
Open Access
- 1 December 2011
- journal article
- research article
- Published by Elsevier in Molecular Pharmacology
- Vol. 80 (6) , 979-987
Abstract
Exposure to the anticonvulsant valproic acid (VPA) during the first trimester of pregnancy is associated with an increased risk of congenital malformations including heart defects, craniofacial abnormalities, skeletal and limb defects, and, most frequently, neural tube defects (NTDs). The mechanisms by which VPA induces teratogenic effects are not fully understood, although previous studies support a role for oxidative stress. To investigate the effects of VPA on early development, a whole-embryo culture model was used to evaluate the protective effects of antioxidants, measure intracellular reactive oxygen species (ROS) levels, and assess markers of oxidative damage and apoptosis. Furthermore, in vivo teratological evaluations of antioxidant protection were also completed. VPA (0.60 mM in embryo culture, 400 mg/kg in vivo) induced significant decreases in embryonic growth and increases in NTDs. Of the antioxidants tested, catalase provided partial protection against VPA-mediated reductions in morphological and developmental growth parameters in both whole-embryo culture and in vivo systems. VPA exposure resulted in an increase in ROS staining in the head region, as assessed by whole-mount staining with 5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate. Markers of embryonic oxidative damage including 8-hydroxyguanosine, 4-hydroxynonenal adducts, and 3-nitrotyrosine were not affected by VPA treatment. Increased ROS levels were correlated with increased staining for apoptotic markers, as assessed by Western blotting and immunohistochemistry. Addition of catalase to the medium attenuated VPA-induced increases in ROS formation and apoptosis. These studies identify regions of the embryo susceptible to ROS and apoptosis induced by VPA, thus establishing a possible molecular pathway by which VPA exerts teratogenicity.Keywords
This publication has 38 references indexed in Scilit:
- Epigenetic modifications in valproic acid-induced teratogenesisToxicology and Applied Pharmacology, 2010
- Ascorbic Acid Reverses Valproic Acid-Induced Inhibition of Hoxa2 and Maintains Glutathione Homeostasis in Mouse Embryos in CultureCellular and Molecular Neurobiology, 2009
- Antiepileptic drug use in women of childbearing ageEpilepsy & Behavior, 2009
- Valproic acid in pregnancy: How much are we endangering the embryo and fetus?Reproductive Toxicology, 2009
- Apoptosis is not required for mammalian neural tube closureProceedings of the National Academy of Sciences, 2009
- Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic DrugsNew England Journal of Medicine, 2009
- Treatment of migraine with prophylactic drugsExpert Opinion on Pharmacotherapy, 2008
- Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapyCancer Letters, 2008
- Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicityBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2005
- The genetic basis of mammalian neurulationNature Reviews Genetics, 2003